{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T10:02:31Z","timestamp":1779876151133,"version":"3.53.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,27]]},"DOI":"10.7759\/cureus.109720","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T09:06:36Z","timestamp":1779872796000},"source":"Crossref","is-referenced-by-count":0,"title":["The Ateq Protocol: A Novel Mathematical Model for Predicting ECG Voltage and Detecting Early Metabolic Hypertension"],"prefix":"10.7759","author":[{"given":"Amany H","family":"Ateq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-019-0244-2","article-title":"The global epidemiology of hypertension","volume":"16","author":"Mills KT","year":"2020","unstructured":"Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020, 16:223-37. 10.1038\/s41581-019-0244-2","journal-title":"Nat Rev Nephrol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.13820","article-title":"Investigation and treatment of high blood pressure in young people: too much medicine or appropriate risk reduction?","volume":"75","author":"Hinton TC","year":"2020","unstructured":"Hinton TC, Adams ZH, Baker RP, Hope KA, Paton JF, Hart EC, Nightingale AK. Investigation and treatment of high blood pressure in young people: too much medicine or appropriate risk reduction?. Hypertension. 2020, 75:16-22. 10.1161\/HYPERTENSIONAHA.119.13820","journal-title":"Hypertension"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.101.3.329","article-title":"Essential hypertension. Part I: definition and etiology","volume":"101","author":"Carretero OA","year":"2000","unstructured":"Carretero OA, Oparil S. Essential hypertension. Part I: definition and etiology. Circulation. 2000, 101:329-35. 10.1161\/01.cir.101.3.329","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2337\/diab.37.12.1595","article-title":"Banting lecture 1988. Role of insulin resistance in human disease","volume":"37","author":"Reaven GM","year":"1988","unstructured":"Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988, 37:1595-607. 10.2337\/diab.37.12.1595","journal-title":"Diabetes"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.14.3.173","article-title":"Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease","volume":"14","author":"DeFronzo RA","year":"1991","unstructured":"DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991, 14:173-94. 10.2337\/diacare.14.3.173","journal-title":"Diabetes Care"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198708063170605","article-title":"Insulin resistance in essential hypertension","volume":"317","author":"Ferrannini E","year":"1987","unstructured":"Ferrannini E, Buzzigoli G, Bonadonna R, et al.. Insulin resistance in essential hypertension. N Engl J Med. 1987, 317:350-7. 10.1056\/NEJM198708063170605","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200103001-00001","article-title":"Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why)","volume":"19","author":"Landsberg L","year":"2001","unstructured":"Landsberg L. Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why). J Hypertens. 2001, 19:523-8. 10.1097\/00004872-200103001-00001","journal-title":"J Hypertens"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/HYP.0000000000000065","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APHA\/ash\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"71","author":"Whelton PK","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, et al.. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APHA\/ash\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines. Hypertension. 2018, 71:e13-e115. 10.1161\/HYP.0000000000000065","journal-title":"Hypertension"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199005313222203","article-title":"Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study","volume":"322","author":"Levy D","year":"1990","unstructured":"Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990, 322:1561-6. 10.1056\/NEJM199005313222203","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.191097","article-title":"AHA\/ACCF\/HRS recommendations for the standardization and interpretation of the electrocardiogram: part V: electrocardiogram changes associated with cardiac chamber hypertrophy: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: endorsed by the International Society for Computerized Electrocardiology","volume":"119","author":"Hancock EW","year":"2009","unstructured":"Hancock EW, Deal BJ, Mirvis DM, et al.. AHA\/ACCF\/HRS recommendations for the standardization and interpretation of the electrocardiogram: part V: electrocardiogram changes associated with cardiac chamber hypertrophy: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: endorsed by the International Society for Computerized Electrocardiology. Circulation. 2009, 119:e251-61. 10.1161\/CIRCULATIONAHA.108.191097","journal-title":"Circulation"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2007.04.006","article-title":"Clinical and echocardiographic correlates of plasma procollagen type III amino-terminal peptide levels in the community","volume":"154","author":"Wang TJ","year":"2007","unstructured":"Wang TJ, Larson MG, Benjamin EJ, et al.. Clinical and echocardiographic correlates of plasma procollagen type III amino-terminal peptide levels in the community. Am Heart J. 2007, 154:291-7. 10.1016\/j.ahj.2007.04.006","journal-title":"Am Heart J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.103.6.836","article-title":"Dyslipidemia and an unfavorable fatty acid profile predict left ventricular hypertrophy 20 years later","volume":"103","author":"Sundstr\u00f6m J","year":"2001","unstructured":"Sundstr\u00f6m J, Lind L, Vessby B, Andr\u00e9n B, Aro A, Lithell H. Dyslipidemia and an unfavorable fatty acid profile predict left ventricular hypertrophy 20 years later. Circulation. 2001, 103:836-41. 10.1161\/01.cir.103.6.836","journal-title":"Circulation"},{"key":"ref13","unstructured":"JASP team. JASP (version 0.18.3). Accessed: January 29, 2026: https:\/\/jasp-stats.org\/."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyw075","article-title":"Maelstrom Research guidelines for rigorous retrospective data harmonization","volume":"46","author":"Fortier I","year":"2017","unstructured":"Fortier I, Raina P, Van den Heuvel ER, et al.. Maelstrom Research guidelines for rigorous retrospective data harmonization. Int J Epidemiol. 2017, 46:103-5. 10.1093\/ije\/dyw075","journal-title":"Int J Epidemiol"},{"key":"ref15","article-title":"National health and nutrition examination survey: sample design, 2011-2014","author":"Johnson CL","year":"2014","unstructured":"Johnson CL, Dohrmann SM, Burt VL, Mohadjer LK. National health and nutrition examination survey: sample design, 2011-2014. Vital Health Stat 2. 2014, 1-33.","journal-title":"Vital Health Stat 2"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.85.7.6661","article-title":"Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans","volume":"85","author":"Katz A","year":"2000","unstructured":"Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000, 85:2402-10. 10.1210\/jcem.85.7.6661","journal-title":"J Clin Endocrinol Metab"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(49)90562-1","article-title":"The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads","volume":"37","author":"Sokolow M","year":"1949","unstructured":"Sokolow M, Lyon TP. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J. 1949, 37:161-86. 10.1016\/0002-8703(49)90562-1","journal-title":"Am Heart J"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews DR","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985, 28:412-19. 10.1007\/BF00280883","journal-title":"Diabetologia"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31919-5","article-title":"Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19\u00b71 million participants","volume":"389","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2017","unstructured":"NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19\u00b71 million participants. Lancet. 2017, 389:37-55. 10.1016\/S0140-6736(16)31919-5","journal-title":"Lancet"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.14.4.33","article-title":"Relationship between insulin resistance and hypertension","volume":"14 Suppl 4","author":"Reaven GM","year":"1991","unstructured":"Reaven GM. Relationship between insulin resistance and hypertension. Diabetes Care. 1991, 14 Suppl 4:33-8. 10.2337\/diacare.14.4.33","journal-title":"Diabetes Care"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0800885","article-title":"Uric acid and cardiovascular risk","volume":"359","author":"Feig DI","year":"2008","unstructured":"Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med. 2008, 359:1811-21. 10.1056\/NEJMra0800885","journal-title":"N Engl J Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.19.2350","article-title":"Prognostic significance of left ventricular mass change during treatment of hypertension","volume":"292","author":"Devereux RB","year":"2004","unstructured":"Devereux RB, Wachtell K, Gerdts E, et al.. Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA. 2004, 292:2350-6. 10.1001\/jama.292.19.2350","journal-title":"JAMA"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/jhh.2011.104","article-title":"Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies","volume":"26","author":"Cuspidi C","year":"2012","unstructured":"Cuspidi C, Sala C, Negri F, Mancia G, Morganti A. Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies. J Hum Hypertens. 2012, 26:343-9. 10.1038\/jhh.2011.104","journal-title":"J Hum Hypertens"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1172\/JCI111776","article-title":"Hyperinsulinemia. A link between hypertension obesity and glucose intolerance","volume":"75","author":"Modan M","year":"1985","unstructured":"Modan M, Halkin H, Almog S, et al.. Hyperinsulinemia. A link between hypertension obesity and glucose intolerance. J Clin Invest. 1985, 75:809-17. 10.1172\/JCI111776","journal-title":"J Clin Invest"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00026.2004","article-title":"Insulin resistance and hypertension","volume":"286","author":"Sowers JR","year":"2004","unstructured":"Sowers JR. Insulin resistance and hypertension. Am J Physiol Heart Circ Physiol. 2004, 286:H1597-602. 10.1152\/ajpheart.00026.2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000069700.62727.C5","article-title":"Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?","volume":"41","author":"Johnson RJ","year":"2003","unstructured":"Johnson RJ, Kang DH, Feig D, et al.. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?. Hypertension. 2003, 41:1183-90. 10.1161\/01.HYP.0000069700.62727.C5","journal-title":"Hypertension"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz203","article-title":"A randomized controlled trial of metformin on left ventricular hypertrophy in patients with coronary artery disease without diabetes: the MET-REMODEL trial","volume":"40","author":"Mohan M","year":"2019","unstructured":"Mohan M, Al-Talabany S, McKinnie A, et al.. A randomized controlled trial of metformin on left ventricular hypertrophy in patients with coronary artery disease without diabetes: the MET-REMODEL trial. Eur Heart J. 2019, 40:3409-17. 10.1093\/eurheartj\/ehz203","journal-title":"Eur Heart J"},{"key":"ref28","unstructured":"Google Colab. a cloud-based platform for computational modeling and data visualization. Accessed: February 13, 2026: https:\/\/colab.research.google.com\/."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/460100-the-ateq-protocol-a-novel-mathematical-model-for-predicting-ecg-voltage-and-detecting-early-metabolic-hypertension","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T09:06:42Z","timestamp":1779872802000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/460100-the-ateq-protocol-a-novel-mathematical-model-for-predicting-ecg-voltage-and-detecting-early-metabolic-hypertension"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.109720","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,27]]}}}